{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T08:26:15Z","timestamp":1774945575450,"version":"3.50.1"},"reference-count":27,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,2,23]],"date-time":"2023-02-23T00:00:00Z","timestamp":1677110400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pediatr."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Due to the growing evidence of the efficacy of intravenous (IV) cefazolin with an early switch to oral cefalexin in uncomplicated pediatric osteomyelitis (OM) and septic arthritis (SA) in children, we changed our guidelines for empiric antibiotic therapy in these conditions. This study aims at evaluating the impact of the guidelines' implementation in reducing broad-spectrum antibiotic prescriptions, duration of IV antibiotic treatment and hospital stay, treatment failure and recurrence.<\/jats:p><\/jats:sec><jats:sec><jats:title>Materials and methods<\/jats:title><jats:p>This is a retrospective, observational, quasi-experimental study. The four years pre-intervention were compared to the six years, ten months post-intervention (January 2012, through December 2015; January 2016, through October 31st, 2022). All patients aged 3 months to 18 years with OM or SA were evaluated for inclusion. Each population was divided into three groups: pre-intervention, post-intervention not following the guidelines, and post-intervention following the guidelines. Differences in antibiotic prescriptions such as Days of Therapy (DOT), activity spectrum and Length of Therapy (LOT), length of hospital stay (LOS), broad-spectrum antibiotics duration (bsDOT), treatment failure and relapse at six months were analyzed as outcomes.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Of 87 included patients, 48 were diagnosed with OM (8 pre-intervention, 9 post-intervention not following the guidelines and 31 post-intervention following the guidelines) and 39 with SA (9 pre-intervention, 12 post-intervention not following the guidelines and 18 post-intervention following the guidelines). In OM patients, IV DOT, DOT\/LOT ratio, and bsDOT were significantly lower in the guidelines group, with also the lowest proportion of patients discharged on IV treatment. Notably, significantly fewer cases required surgery in the post-intervention groups. Considering SA, LOS, IV DOT, DOT\/LOT ratio, and bsDOT were significantly lower in the guidelines group. The treatment failure rate was comparable among all groups for both OM and SA. There were no relapse cases. The overall adherence was between 72 and 100%.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>The implementation of guidelines was effective in decreasing the extensive use of broad-spectrum antibiotics and combination therapy for both OM and SA. Our results show the applicability, safety, and efficacy of a narrow-spectrum IV empirical antibiotic regimen with cefazolin, followed by oral monotherapy with first\/second-generation cephalosporins, which was non-inferior to broad-spectrum regimens.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fped.2023.1135319","type":"journal-article","created":{"date-parts":[[2023,2,23]],"date-time":"2023-02-23T09:58:55Z","timestamp":1677146335000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":8,"title":["Impact of guidelines implementation on empiric antibiotic treatment for pediatric uncomplicated osteomyelitis and septic arthritis over a ten-year period: Results of the ELECTRIC study (ostEomyeLitis and sEptiC arThritis tReatment in children)"],"prefix":"10.3389","volume":"11","author":[{"given":"Chiara","family":"Minotti","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesca","family":"Tirelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chiara","family":"Guariento","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giulia","family":"Sturniolo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlo","family":"Giaquinto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liviana","family":"Da Dalt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesco","family":"Zulian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessandra","family":"Meneghel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giorgia","family":"Martini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniele","family":"Don\u00e0","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2023,2,23]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1302\/0301-620X.94B5.28523","article-title":"Haematogenous acute and subacute paediatric osteomyelitis","author":"Dartnell","year":"2012","journal-title":"J Bone Joint Surg Br"},{"key":"B2","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/s1521-6942(02)00106-7","article-title":"Septic arthritis","volume":"17","author":"Nade","year":"2003","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"B3","doi-asserted-by":"publisher","first-page":"e204","DOI":"10.3928\/00904481-20160428-01","article-title":"Acute hematogenous osteomyelitis in children","volume":"45","author":"Whyte","year":"2016","journal-title":"Pediatr Ann"},{"key":"B4","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1016\/j.jor.2017.06.004","article-title":"Nationwide survey of pediatric septic arthritis in the United States","volume":"14","author":"Okubo","year":"2017","journal-title":"J Orthop"},{"key":"B5","doi-asserted-by":"publisher","first-page":"3557","DOI":"10.3390\/ijerph16193557","article-title":"Practical issues in early switching from intravenous to oral antibiotic therapy in children with uncomplicated acute hematogenous osteomyelitis: results from an Italian survey","volume":"16","author":"Chiappini","year":"2019","journal-title":"Int J Environ Res Public Health"},{"key":"B6","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1007\/s12519-020-00359-z","article-title":"Acute infectious osteomyelitis in children: new treatment strategies for an old enemy","volume":"16","author":"Congedi","year":"2020","journal-title":"World J Pediatr"},{"key":"B7","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1097\/INF.0000000000001635","article-title":"Bone and joint infections","volume":"36","author":"Saavedra-Lozano","year":"2017","journal-title":"Pediatr Infect Dis J"},{"key":"B8","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1093\/jpids\/piab027","article-title":"Clinical practice guideline by the pediatric infectious diseases society and the infectious diseases society of America: 2021 guideline on diagnosis and management of acute hematogenous osteomyelitis in pediatrics","volume":"10","author":"Woods","year":"2021","journal-title":"J Pediatric Infect Dis Soc"},{"key":"B9","doi-asserted-by":"publisher","first-page":"2254","DOI":"10.1001\/archinte.168.20.2254","article-title":"Trends in antibacterial use in US academic health centers: 2002 to 2006","volume":"168","author":"Pakyz","year":"2008","journal-title":"Arch Intern Med"},{"key":"B10","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1086\/511640","article-title":"Measurement of adult antibacterial drug use in 130 US hospitals: comparison of defined daily dose and days of therapy","volume":"44","author":"Polk","year":"2007","journal-title":"Clin Infect Dis"},{"key":"B11","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1093\/cid\/cir672","article-title":"Benchmarking risk-adjusted adult antibacterial drug use in 70 US academic medical center hospitals","volume":"53","author":"Polk","year":"2011","journal-title":"Clin Infect Dis"},{"key":"B12","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1001\/jamapediatrics.2014.2822","article-title":"Comparative effectiveness of intravenous vs. oral antibiotics for postdischarge treatment of acute osteomyelitis in children","volume":"169","author":"Keren","year":"2015","journal-title":"JAMA Pediatr"},{"key":"B13","doi-asserted-by":"publisher","first-page":"18","DOI":"10.12968\/hmed.2015.76.1.18","article-title":"Panton-Valentine leukocidin osteomyelitis in children: a growing threat","volume":"76","author":"Sheikh","year":"2015","journal-title":"Br J Hosp Med (Lond)"},{"key":"B14","doi-asserted-by":"publisher","first-page":"e17185","DOI":"10.1097\/MD.0000000000017185","article-title":"Severe infections of panton-valentine leukocidin positive Staphylococcus aureus in children","volume":"98","author":"Hoppe","year":"2019","journal-title":"Medicine (Baltimore)"},{"key":"B15","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1542\/peds.2005-0566","article-title":"Panton-Valentine leukocidin genes are associated with enhanced inflammatory response and local disease in acute hematogenous Staphylococcus aureus osteomyelitis in children","volume":"117","author":"Bocchini","year":"2006","journal-title":"Pediatrics"},{"key":"B16","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1097\/INF.0b013e31824041b8","article-title":"Antibiotic susceptibility of Kingella kingae isolates from children with skeletal system infections","volume":"31","author":"Yagupsky","year":"2012","journal-title":"Pediatr Infect Dis J"},{"key":"B17","doi-asserted-by":"publisher","first-page":"273.e1","DOI":"10.1016\/j.anpedi.2014.10.005","article-title":"[SEIP-SERPE-SEOP consensus document on the treatment of uncomplicated acute osteomyelitis and septic arthritis]","volume":"82","author":"Saavedra-Lozano","year":"2015","journal-title":"An Pediatr (Barc)"},{"key":"B18","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1097\/MOP.0b013e32835c2b42","article-title":"Osteomyelitis and septic arthritis in children: current concepts","volume":"25","author":"Dodwell","year":"2013","journal-title":"Curr Opin Pediatr"},{"key":"B19","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1086\/597582","article-title":"Prospective, randomized trial of 10 days versus 30 days of antimicrobial treatment, including a short-term course of parenteral therapy, for childhood septic arthritis","volume":"48","author":"Peltola","year":"2009","journal-title":"Clin Infect Dis"},{"key":"B20","doi-asserted-by":"publisher","first-page":"S74","DOI":"10.1016\/S0929-693X(08)74220-9","article-title":"[Osteoarticular infections: therapeutic proposals of the paediatric infectious diseases group of the French society of paediatrics (GPIP)]","volume":"15","author":"Grimprel","year":"2008","journal-title":"Arch Pediatr"},{"key":"B21","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1016\/j.arcped.2011.05.015","article-title":"Antibiotic therapy of bone and joint infections in children: recent changes","volume":"18","author":"Lorrot","year":"2011","journal-title":"Arch Pediatr"},{"key":"B22","doi-asserted-by":"publisher","first-page":"e139","DOI":"10.1016\/S1473-3099(16)30024-X","article-title":"Antibiotic duration and timing of the switch from intravenous to oral route for bacterial infections in children: systematic review and guidelines","volume":"16","author":"McMullan","year":"2016","journal-title":"Lancet Infect Dis"},{"key":"B23","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1097\/INF.0b013e3181f55a89","article-title":"Short- versus long-term antimicrobial treatment for acute hematogenous osteomyelitis of childhood: prospective, randomized trial on 131 culture positive cases","volume":"29","author":"Peltola","year":"2010","journal-title":"Pediatr Infect Dis J"},{"key":"B24","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1542\/peds.2008-0596","article-title":"Prolonged intravenous therapy versus early transition to oral antimicrobial therapy for acute osteomyelitis in children","volume":"123","author":"Zaoutis","year":"2009","journal-title":"Pediatrics"},{"key":"B25","doi-asserted-by":"publisher","first-page":"683","DOI":"10.3109\/00365548.2012.673729","article-title":"Shortened hospital stay for childhood bone and joint infections: analysis of 265 prospectively collected culture positive cases in 1983\u20132005","volume":"44","author":"P\u00e4\u00e4kk\u00f6nen","year":"2012","journal-title":"Scand J Infect Dis"},{"key":"B26","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1002\/phar.2160","article-title":"Management of pediatric acute hematogenous osteomyelitis, part I: antimicrobial stewardship approach and review of therapies for methicillin-susceptible Staphylococcus aureus, Streptococcus pyogenes, and Kingella kingae","volume":"38","author":"DeRonde","year":"2018","journal-title":"Pharmacotherapy"},{"key":"B27","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1056\/NEJMoa1710926","article-title":"Oral versus intravenous antibiotics for bone and joint infection","volume":"380","author":"Li","year":"2019","journal-title":"N Engl J Med"}],"container-title":["Frontiers in Pediatrics"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2023.1135319\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,23]],"date-time":"2023-02-23T09:58:58Z","timestamp":1677146338000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2023.1135319\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,23]]},"references-count":27,"alternative-id":["10.3389\/fped.2023.1135319"],"URL":"https:\/\/doi.org\/10.3389\/fped.2023.1135319","relation":{},"ISSN":["2296-2360"],"issn-type":[{"value":"2296-2360","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,23]]},"article-number":"1135319"}}